Inovio prices offering with warrants exercisable at $1.1 per share

• Inovio priced a public offering of 21,052,632 common shares with warrants to buy up to 42,105,264 shares at a $1.1 exercise price.
• Units were priced at $0.95 per share with a warrant for two shares; gross proceeds expected at about $20 million, excluding warrant exercise.
• Underwriter option covers up to 3,157,894 additional shares, warrants for up to 6,315,788 shares, or pre-funded warrants in lieu thereof.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607292053PR_NEWS_USPR_____PH15682) on July 30, 2026, and is solely responsible for the information contained therein.